Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Abstract 71: Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy

Ahmad A. Tarhini, Islam Eljilany, Sam Coleman, Dale J. Hedges, Martin McCarter, John Carpten, Howard Colman, Abdul Rafeh Naqash, Igor Puzanov, Susanne Arnold, Michelle Churchman, Patrick Hwu, William S. Dalton, George J. Weiner, Aik Choon Tan, Jose R. Conejo-Garcia, Paulo C. Rodriguez

Cancer Res (2024) 84 (6_Supplement): 71.

https://doi.org/10.1158/1538-7445.AM2024-71

Published: 22 March 2024

View article titled, Abstract 71: Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy

Journal Articles

Abstract 4: A novel humanized mouse model for study of T cells and NK cells in the tumor microenvironment

Jyoti Arora, Caitlin D. Lemke-Miltner, George J. Weiner

Cancer Res (2023) 83 (7_Supplement): 4.

https://doi.org/10.1158/1538-7445.AM2023-4

Published: 04 April 2023

View article titled, Abstract 4: A novel humanized mouse model for study of T cells and NK cells in the tumor microenvironment

Journal Articles

Abstract 3313: A novel RNA aptamer-based assay for quantifying fractional occupancy of PD1 by PDL1 in formalin fixed biospecimens

Suresh Veeramani, Nanmeng Yu, Xian Jin Xie, Kristen Coleman, George J. Weiner

Cancer Res (2023) 83 (7_Supplement): 3313.

https://doi.org/10.1158/1538-7445.AM2023-3313

Published: 04 April 2023

View article titled, Abstract 3313: A novel RNA aptamer-based assay for quantifying fractional occupancy of PD1 by PDL1 in formalin fixed biospecimens

Journal Articles

Abstract 5703: The immune cell state atlas analysis predicts therapeutic benefits with immune checkpoint inhibitors

Tingyi Li, Vineeth Sukrithan, Aakrosh Ratan, Martin McCarter, John Carpten, Howard Colman, Alexandra P. Ikeguchi, Igor Puzanov, Susanne Arnold, Michelle Churchman, Patrick Hwu, Paulo C. Rodriguez, William S. Dalton, George J. Weiner, Ahmad Tarhini, Xuefeng Wang

Cancer Res (2023) 83 (7_Supplement): 5703.

https://doi.org/10.1158/1538-7445.AM2023-5703

Published: 04 April 2023

View article titled, Abstract 5703: The immune cell state atlas analysis predicts therapeutic benefits with immune checkpoint inhibitors

Journal Articles

Abstract 2804: Generation of RNA aptamers for measuring fractional occupancy of PD1 by PDL1

Suresh Veeramani, Travis Fischer, William H. Thiel, George J. Weiner

Cancer Res (2022) 82 (12_Supplement): 2804.

https://doi.org/10.1158/1538-7445.AM2022-2804

Published: 15 June 2022

View article titled, Abstract 2804: Generation of RNA aptamers for measuring fractional occupancy of PD1 by PDL1

Journal Articles

Abstract 5596: TNFα production by myeloid DCs in response to rituximab induces monocyte and NK cell proliferation and survival

Nanmeng Yu, George J. Weiner

Cancer Res (2022) 82 (12_Supplement): 5596.

https://doi.org/10.1158/1538-7445.AM2022-5596

Published: 15 June 2022

View article titled, Abstract 5596: TNFα production by myeloid DCs in response to rituximab induces monocyte and NK cell proliferation and survival

Journal Articles

Abstract LB107: Novel transcriptional signatures associated with antitumor activity in vidutolimod (vidu)-treated patients (pts) with anti-PD-1-refractory melanoma and non-small cell lung cancer (NSCLC)

Hong Liu, Luping Zhao, Ping Zheng, Riyue Bao, Jason J. Luke, Marcelo V. Negrao, Shakoora A. Sabree, George J. Weiner, Sujatha Kumar, Dmitri Bobilev, James E. Wooldridge, Arthur M. Krieg

Cancer Res (2022) 82 (12_Supplement): LB107.

https://doi.org/10.1158/1538-7445.AM2022-LB107

Published: 15 June 2022

View article titled, Abstract LB107: Novel transcriptional signatures associated with antitumor activity in vidutolimod (vidu)-treated patients (pts) with anti-PD-1-refractory melanoma and non-small cell lung cancer (NSCLC)

Journal Articles

Abstract 1687: T cells are required to maintain anti-CD20-mediated NK cell responses in vitro

Zhaoming Wang, George J. Weiner

Cancer Res (2021) 81 (13_Supplement): 1687.

https://doi.org/10.1158/1538-7445.AM2021-1687

Published: 01 July 2021

View article titled, Abstract 1687: T cells are required to maintain anti-CD20-mediated NK cell responses in vitro

Journal Articles

Abstract 1699: Direct and indirect immune effects of CMP-001, a virus like particle containing a TLR9 agonist

Shakoora Sabree, Andrew Voigt, George J. Weiner, Sue Blackwell

Cancer Res (2021) 81 (13_Supplement): 1699.

https://doi.org/10.1158/1538-7445.AM2021-1699

Published: 01 July 2021

View article titled, Abstract 1699: Direct and indirect immune effects of CMP-001, a virus like particle containing a TLR9 agonist

Journal Articles

Abstract 909: The role of checkpoints in Rituximab-mediated NK cell activation

Zhaoming Wang, George J. Weiner

Cancer Res (2020) 80 (16_Supplement): 909.

https://doi.org/10.1158/1538-7445.AM2020-909

Published: 15 August 2020

View article titled, Abstract 909: The role of checkpoints in Rituximab-mediated NK cell activation

Journal Articles

Abstract 4333: Unoccupied and IL2-occupied soluble CD25 have distinct prognostic effects in follicular lymphoma

Suresh Veeramani, Sue E. Blackwell, Paula Banuelos, Zhi-Zhang Yang, Stephen M. Ansell, George J. Weiner

Cancer Res (2020) 80 (16_Supplement): 4333.

https://doi.org/10.1158/1538-7445.AM2020-4333

Published: 15 August 2020

View article titled, Abstract 4333: Unoccupied and IL2-occupied soluble CD25 have distinct prognostic effects in follicular lymphoma

Journal Articles

Abstract 6666: Evaluation of the complexity of the immune response to CMP-001, a TLR9 agonist

Shakoora Sabree, Andrew Voigt, Laura Rogers, Sue Blackwell, Caitlin Lemke-Miltner, George J. Weiner

Cancer Res (2020) 80 (16_Supplement): 6666.

https://doi.org/10.1158/1538-7445.AM2020-6666

Published: 15 August 2020

View article titled, Abstract 6666: Evaluation of the complexity of the immune response to CMP-001, a TLR9 agonist

Journal Articles

Abstract 1606: Targeting human T regulatory cells with novel Interleukin 2 alpha - IL2 complex-specific RNA aptamer

Suresh Veeramani, Sue E. Blackwell, William H. Thiel, Paloma H. Giangrande, George J. Weiner

Cancer Res (2017) 77 (13_Supplement): 1606.

https://doi.org/10.1158/1538-7445.AM2017-1606

Published: 01 July 2017

View article titled, Abstract 1606: Targeting human T regulatory cells with novel Interleukin 2 alpha - IL2 complex-specific RNA aptamer

Journal Articles

Abstract 546: Impact of therapeutic EGFR inhibition on immune checkpoint blockade in head and neck squamous cell carcinoma

Laura M. Rogers, Madelyn M. Espinosa-Cotton, Andrean L. Simons, George J. Weiner

Cancer Res (2016) 76 (14_Supplement): 546.

https://doi.org/10.1158/1538-7445.AM2016-546

Published: 15 July 2016

View article titled, Abstract 546: Impact of therapeutic EGFR inhibition on immune checkpoint blockade in head and neck squamous cell carcinoma

Journal Articles

Abstract 526: Identification of novel cancer immunotherapy targets using Sleeping Beauty mutagenesis

Laura M. Rogers, Adam J. Dupuy, George J. Weiner

Cancer Res (2016) 76 (14_Supplement): 526.

https://doi.org/10.1158/1538-7445.AM2016-526

Published: 15 July 2016

View article titled, Abstract 526: Identification of novel cancer immunotherapy targets using Sleeping Beauty mutagenesis

Journal Articles

Essential Components of Cancer Education

Danny R. Welch, Toni M. Antalis, Kerry Burnstein, Linda Vona-Davis, Roy A. Jensen, Harikrishna Nakshatri, Anna T. Riegel, Douglas R. Spitz, Dennis K. Watson, George J. Weiner

Cancer Res (2015) 75 (24): 5202–5205.

https://doi.org/10.1158/0008-5472.CAN-15-2077

Published: 14 December 2015

View article titled, Essential Components of Cancer Education

Journal Articles

Abstract 5022: Generation of T regulatory-cell specific RNA aptamers

Suresh Veeramani, Sue E. Blackwell, William H. Thiel, Paloma H. Giangrande, George J. Weiner

Cancer Res (2015) 75 (15_Supplement): 5022.

https://doi.org/10.1158/1538-7445.AM2015-5022

Published: 01 August 2015

View article titled, Abstract 5022: Generation of T regulatory-cell specific RNA aptamers

Journal Articles

Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

Amani Makkouk, George J. Weiner

Cancer Res (2015) 75 (1): 5–10.

https://doi.org/10.1158/0008-5472.CAN-14-2538

Published: 04 January 2015

View article titled, Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

Journal Articles

Abstract 5393: C5a complement enhances generation of APC-induced Foxp3+ T regulatory cells

Suresh Veeramani, George J. Weiner

Cancer Res (2012) 72 (8_Supplement): 5393.

https://doi.org/10.1158/1538-7445.AM2012-5393

Published: 15 April 2012

View article titled, Abstract 5393: C5a complement enhances generation of APC-induced Foxp3+ T regulatory cells

Journal Articles

Abstract LB-152: Complement promotes induction of Foxp3+ T regulatory cells by B lymphoma cells and professional antigen-presenting cells

Suresh Veeramani, Christopher E. Dahle, George J. Weiner

Cancer Res (2011) 71 (8_Supplement): LB-152.

https://doi.org/10.1158/1538-7445.AM2011-LB-152

Published: 15 April 2011

View article titled, Abstract LB-152: Complement promotes induction of Foxp3+ T regulatory cells by B lymphoma cells and professional antigen-presenting cells

NARROW

Abstract 71: Differential infiltration of key immune cell populations across malignancies varying by immunogenic potential and likelihood of response to immunotherapy

Abstract 4: A novel humanized mouse model for study of T cells and NK cells in the tumor microenvironment

Abstract 3313: A novel RNA aptamer-based assay for quantifying fractional occupancy of PD1 by PDL1 in formalin fixed biospecimens

Abstract 5703: The immune cell state atlas analysis predicts therapeutic benefits with immune checkpoint inhibitors

Abstract 2804: Generation of RNA aptamers for measuring fractional occupancy of PD1 by PDL1

Abstract 5596: TNFα production by myeloid DCs in response to rituximab induces monocyte and NK cell proliferation and survival

Abstract LB107: Novel transcriptional signatures associated with antitumor activity in vidutolimod (vidu)-treated patients (pts) with anti-PD-1-refractory melanoma and non-small cell lung cancer (NSCLC)

Abstract 1687: T cells are required to maintain anti-CD20-mediated NK cell responses in vitro

Abstract 1699: Direct and indirect immune effects of CMP-001, a virus like particle containing a TLR9 agonist

Abstract 909: The role of checkpoints in Rituximab-mediated NK cell activation

Abstract 4333: Unoccupied and IL2-occupied soluble CD25 have distinct prognostic effects in follicular lymphoma

Abstract 6666: Evaluation of the complexity of the immune response to CMP-001, a TLR9 agonist

Abstract 1606: Targeting human T regulatory cells with novel Interleukin 2 alpha - IL2 complex-specific RNA aptamer

Abstract 546: Impact of therapeutic EGFR inhibition on immune checkpoint blockade in head and neck squamous cell carcinoma

Abstract 526: Identification of novel cancer immunotherapy targets using Sleeping Beauty mutagenesis

Essential Components of Cancer Education

Abstract 5022: Generation of T regulatory-cell specific RNA aptamers

Cancer Immunotherapy and Breaking Immune Tolerance: New Approaches to an Old Challenge

Abstract 5393: C5a complement enhances generation of APC-induced Foxp3+ T regulatory cells

Abstract LB-152: Complement promotes induction of Foxp3+ T regulatory cells by B lymphoma cells and professional antigen-presenting cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only